Stock Analysis on Net

Edwards Lifesciences Corp. (NYSE:EW)

$22.49

This company has been moved to the archive! The financial data has not been updated since February 14, 2022.

Price to Book Value (P/BV)
since 2005

Microsoft Excel

Calculation

Edwards Lifesciences Corp., P/BV, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$

2 Data adjusted for splits and stock dividends.

3 Closing price as at the filing date of Edwards Lifesciences Corp. Annual Report.


The financial data reveals a consistent upward trend in the share price over the analyzed 17-year period. Starting from a relatively low value of 3.48 US dollars in 2006, the share price experienced fluctuations in the initial years but generally showed significant growth, especially from 2010 onwards. The share price accelerated markedly from 22.41 US dollars in 2015 to 107.73 US dollars in 2022, indicating strong market performance and investor confidence.

Book value per share (BVPS) also showed steady growth over the period. Beginning at 0.97 US dollars in 2006, the BVPS increased gradually each year, reaching 9.36 US dollars by 2022. This suggests that the company's net asset value per share has consistently improved, reflecting accumulated retained earnings and potentially enhanced asset quality or capital adequacy.

The price-to-book value (P/BV) ratio exhibits a more volatile pattern with an overall upward trend. Initially around 3.59 in 2006, the ratio experienced fluctuations and peaked at 7.46 in 2011. After some variations, there was a pronounced increase from 7.28 in 2017 to a peak of 11.97 in 2021, slightly receding to 11.5 by 2022. The elevated P/BV ratios over the latter years indicate that the market valuation significantly exceeds the book value, which could be associated with high growth expectations, intangible assets, or market speculation.

In summary, the data points to substantial appreciation in market valuation, outpacing the growth in book value per share. The elevated and rising P/BV ratios in the later years suggest an increasingly positive market sentiment towards the company's future prospects, though also imply higher market valuations relative to the company's accounting value.

Share Price Trends
Consistent increase with significant growth from 2010 onwards; increased from 3.48 to 107.73 US dollars over 17 years.
Book Value per Share (BVPS) Trends
Steady growth indicating improved net asset value per share; increased from 0.97 to 9.36 US dollars over the period.
Price-to-Book Value (P/BV) Ratio Trends
Fluctuating but generally rising ratio; moved from 3.59 in 2006 to peaks near 12 in recent years, reflecting heightened market valuations relative to book value.
Insight on Valuation
Market price appreciation exceeds book value growth, signaling strong investor expectations and potentially premium valuation.

Comparison to Competitors

Edwards Lifesciences Corp., P/BV, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Sector (Health Care Equipment & Services)

Edwards Lifesciences Corp., P/BV, long-term trends, comparison to sector (health care equipment & services)

Microsoft Excel

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Industry (Health Care)

Edwards Lifesciences Corp., P/BV, long-term trends, comparison to industry (health care)

Microsoft Excel

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).